The Board of Directors of First National Equities Limited, in its emergent meeting today, has granted in-principle approval for the proposed acquisition of 100% equity interest in Albert Pharma (Private) Limited. The acquisition is subject to the completion of due diligence, execution of definitive agreements, and compliance with all applicable regulatory requirements.
The Board has also directed the CEO and Company Secretary to prepare a comprehensive Sharia-compliant business and financial plan, as authorized by shareholders at the Annual General Meeting (AGM) held on October 28, 2025. This plan will outline the company’s strategy to diversify its principal line of business beyond stock brokerage, expanding into pharmaceuticals, healthcare, and allied sectors.
The plan will address the legal and regulatory requirements to ensure smooth implementation and compliance, with the aim of creating long-term value for shareholders. This disclosure is being made to comply with applicable regulatory requirements and to inform market participants accordingly.
